« Return to News | R&D Trends

NIH Pushes Academic Collaboration vs. Competition

Thursday, October 12, 2006 05:46 PM

The National Institutes of Health (NIH) has begun the development of a unique translational research consortium composed of some of the most well renowned top academic health centers (AHC) in the U.S. This is somewhat unique in a research community that has become extremely competitive for NIH grant money.

The 12 initial research centers to be networked into the group received NIH awards totaling around $100 million to fund the project through its first year. The NIH hopes to create a network of 60 AHCs by 2012 receiving a total of $500 million per year.

The push towards research that can quickly translate from the early stages of scientific discoveries into medical applications has been building in both the academic and regulatory communities. One reason for a translational approach to research may be due to the recent slow down in drugs being developed by the pharmaceutical industry. There is little doubt that pharma is aggressively addressing its R&D and market landscape challenges, but it’ll be some time before we see significant progress.

Academic research is painfully expensive. Having the NIH support these kinds of collaborations shows that these agencies understand the issues and are willing to step up to the plate. And for AHCs, grant money in any form, is always welcomed.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.